BNTX
NASDAQ
$92.16
BioNTech SE (BNTX)
BioNTech SE, a biotechnology company, develops and markets immunotherapies for cancer and other infectious diseases. The company is headquartered in Mainz, Germany.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $122.23 (+32.63%)
Market Cap
$23B
Free Cash Flow Yield
0.67%
Beta (5Y)
0.94
Price Chart
Valuation
Market Cap$23B
Forward P/E7.04
P/S8.29
P/B1.07
Profitability
Total Revenue (TTM)$3.23B
Gross Profit (TTM)$2.55B
EBITDA-$814M
Profit Margin-44.6%
Operating Margin-577%
EPS-$5.94
Financial Health
Debt-to-Equity1.6%
Free Cash Flow Yield0.67%
Growth & Risk
Revenue 5Y CAGR+2.17%
Beta (5Y)0.94
Sharpe Ratio-0.33